Emerson confirms plan to buy National Instruments in $8.2 bln deal
Emerson Electric Co. (EMR) said Wednesday it agreed to acquire National Instruments Corp. (NATI) for $60 per share in cash, at an equity value of $8.2 billion. The price amounts to a 14% premium over its closing price of $52.58 on Tuesday. It's also a premium of 49% over NI's closing share price as of Jan. 12, prior to its announcement of a strategic review. The deal comes after reports of a potential tie-up between the two companies was reported by Bloomberg. Emerson currently owns about 2.3 million shares of NI, or 2% of shares outstanding. "With this expansion into test and measurement, Emerson will enhance its automation capabilities and gain a broader set of customers that relies on NI's solutions at critical points along the product development cycle," Emerson CEO Lal Karsanbhai said. Emerson plans to close the acquisition of NI in the first half of its fiscal 2024. Emerson Electric stock is down 1.7% in premarket trades, while National Instruments was up 9.4% prior to a trading halt.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-12-23 0819ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom